Another eye-watering set of numbers from Sequent. Gross margins haven’t improved QoQ and revenues are flat. EBITDA margin down to 0.8%, almost same as last Q.
Europe struggling
Acquired an Indian company called Tineta Pharma which is into livestock and aquaculture formulations. Claim to have a 25 year old presence, strong brand and field force of 270+ in India.
| Subscribe To Our Free Newsletter |
